Kitzerow’s Documented Timeline

The trademark registration for NeuroToggle™ was completed, formally protecting the name of the neuroplasticity-based educational framework developed by Kitzerow.

Kitzerow published an educational series explaining metabolism using a “food truck” analogy to illustrate how nutrients are distributed throughout the body. The series emphasized that nutrients must adequately supply each physiological system and discussed limitations of the traditional food pyramid model.

A paper titled Tetrahydrobiopterin and Autism Spectrum Disorder: A Systematic Review of a Promising Therapeutic Pathway passed peer review and was published in MDPI. Kitzerow later identified significant overlap between the publication and her previously documented hypothesis regarding the role of BH4 within autism and systemic comorbidities.

Kitzerow discovered the newly published BH4 autism review paper and contacted her congressional representative in Washington D.C. to ask what steps could be taken to help translate the findings into research that could assist more children.

Kitzerow explained how tetrahydrobiopterin (BH4) functions as a central regulatory component within the Allostatic Toggles framework, linking stress responses to neurotransmitter synthesis and systemic physiological regulation.

Kitzerow publicly explained how the NeuroToggle™ educational framework was used to help her daughter transition from silence to speech through targeted neuroplasticity-based learning strategies.

Kitzerow published a paper titled BioToggle™ Categorical Delineation: A Functional Framework for Timing-Sensitive Intervention in Neurodivergent Biochemistry. The paper introduces the Toggle-Based Neurotype Classification System™, which maps neurotypes to situational, chronic, or genetically induced BioToggle states. The framework proposes that phenotypes of neurodivergence may vary depending on when regulatory shifts occur during development and how long those shifts persist.

Kitzerow received a return call from her congressional representative asking what she had done to help her nonverbal autistic daughter and how the approach worked. She explained that she synthesized existing research across disciplines to identify the pathology of autism and applied those findings to help her daughter transition from silence to speech. She also informed the representative that her hypothesis had recently appeared in a peer-reviewed publication from Brazil that she believes overlaps with her previously documented work.

Kitzerow explained how ADHD traits may be understood within the Neurodivergent Biochemistry framework through regulatory system shifts influencing neurotransmitter signaling and behavioral regulation.

Six days after announcing a federal initiative to determine the biological causes of autism, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. stated that the government would attempt to synthesize existing autism research across disciplines in order to identify underlying mechanisms, particularly for children who remain nonverbal. When asked how the research synthesis would be conducted, a clear methodology was not provided. Instead, officials indicated that researchers would be invited to submit proposals describing how the work could be carried out. Reporting later indicated that a clear pathway for synthesizing the existing literature and biomarker data did not emerge from this process. Subsequent reporting described the release of a report associated with the initiative that drew criticism after errors were identified, with journalists and researchers questioning whether portions of the document may have been generated using artificial intelligence.

Kitzerow introduced a pinball analogy to explain how genetic predispositions interact with epigenetic triggers during real-world situations that activate BioToggle regulatory systems. The analogy illustrated how environmental stressors can shift regulatory pathways depending on existing genetic vulnerabilities.

Kitzerow expanded the Allostatic Toggles framework into BioToggle®, defining regulatory system domains involved in physiological stress adaptation. The BioToggle name was formally trademarked as part of protecting the framework.

Kitzerow explained how her visual models represent the kinetic flow of biochemical activity as the body shifts between allostasis and homeostasis, illustrating how regulatory systems dynamically respond to stress and recovery.

Kitzerow created a flowchart illustrating the kinetic progression of genetically induced allostasis and how chronic regulatory activation may result in a BH4 shunt linking biochemical stress responses to autism and systemic comorbidities.

Kitzerow created educational flyers explaining her Autism and the Comorbidities Theory and the Neurodivergent Biochemistry framework in order to communicate the model and its mechanisms to a broader audience.

Kitzerow published the second volume of NeuroToggle, expanding the educational framework that applies neuroplasticity-informed learning strategies to skill development.

Kitzerow encountered a study conducted in Japan reporting that diverse gene mutations converge on a common physiological outcome, a common and convergent stress response among all autism linked gene mutations. The finding aligned with and independently reinforced a central pillar of her existing framework, which proposes that distinct genetic variations can produce shared stress-response states through convergent biochemical pathways.

Kitzerow began creating the Neurodivergent Biochemistry infographic series, developing visual diagrams that map variables involved in regulatory system shifts and biochemical pathway dynamics.

Kitzerow explained the distinction between the working hypothesis method and the theory-building hypothesis method, outlining how theoretical models are developed through integration of existing research across disciplines.

Kitzerow learned about a Princeton study titled “Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs,” which tests the hypothesis that categories of gene mutations alter biochemical pathway activity and cluster autism traits with comorbid conditions into phenotypic groups.

After discovering the Princeton publication, Kitzerow created a breakdown documenting previous instances where elements of her framework appeared in research publications without attribution, including screenshots of the conversations where she first learned about each instance.

Kitzerow introduced BioDials to explain time-regulated protein synthesis and how temporal regulatory processes guide physiological function and developmental timing.

Stanford researchers published a study examining whether reticular thalamic hyperexcitability drives autism behaviors and reported that reducing this circuit-level hyperactivity improved autism-like traits in a mouse model. The study’s findings reflect the same downstream autism trait mechanism described in Kitzerow’s framework, in which excitatory and inhibitory imbalance within the cortico striatal thalamic loop produces observable behavioral traits. This section also notes prior outreach from Stanford researchers on November 27, 2023 requesting information about Kitzerow’s theory, preceding the development of a treatment targeting this same circuit-level mechanism.

Kitzerow contacted Princeton’s research integrity office regarding the July 2025 publication “Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs.” The complaint was forwarded to the Dean of Faculty.

Naviaux published “A 3-Hit Metabolic Signaling Model for the Core Symptoms of Autism Spectrum Disorder,” introducing a structured three-category stress taxonomy and an expanded signaling sequence involving mitochondrial signaling, neural regulation, developmental timing, and neuroplastic adaptation. The model presents a stepwise cascade that mirrors the structure of Kitzerow’s previously documented framework, including the positioning of neuroplasticity as a downstream mechanism through which outcomes may be improved following disruption of earlier regulatory processes.